Added to YB: 2017-03-16
Pitch date: 2017-03-16
AFMD:US [bullish]
Affimed N.V.
-100%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany.
Market Cap
$10.2M
Pitch Price
$13.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.02
P/E
-0.14
EV/Sales
-0.18
Sector
Biotechnology
Category
N/A
Show full summary:
AFFIMED NV COM AFMD:US
A summary for this pitch has not been created yet.
Read full article (0 min)